Abbott beats profit estimates but suspends forecast on coronavirus concerns

(Reuters) - Abbott Laboratories beat quarterly profit estimates on Thursday as stay-at-home orders prompted customers to stockpile its nutrition products but the company suspended its full-year forecast due to the coronavirus-led uncertainty.Shelter-in-place restrictions imposed by U.S. states boosted sales of Abbott's nutrition products for children such as PediaSure, but crimped demand for its medical devices and non-coronavirus testing kits.Sales in its diagnostics unit fell nearly 1% to..